Pancreatic Cancer Research

ResearcherLeidos Biomedical Research Inc. (United States)Active in the last 2 years

Rachael Z. Stolzenberg‐Solomon

ORCID-verified (high confidence, 0.95), identity_conf@1As of 6 November 2026

Matched on ORCID iD 0000-0003-3698-7006; OpenAlex author ID A5074616706; NIH RePORTER profile ID 9414780. Sources: OpenAlex.

Their work

Papers
102 (first author 5, last author 37)
Trials
0
Grants
3
Labs led
1
Collaborators
179
Papers, trials and grants by year

2011: 8 papers · 2012: 6 papers · 2013: 12 papers · 2014: 9 papers · 2015: 9 papers · 2016: 4 papers · 2017: 8 papers · 2018: 7 papers · 2019: 2 papers · 2020: 6 papers · 2021: 7 papers · 2022: 3 papers · 2023: 5 papers · 2024: 3 papers · 2025: 4 papers, 3 grants · 2026: 9 papers

Papers 50 of 102

  1. Dynamics of the association between circulating levels of miRNA and pancreatic cancer risk through the years prior to pancreatic cancer diagnosis. Co-author DOI 10.1002/ijc.70452↗
  2. Adherence to the Mediterranean diet and risk of pancreatic cancer: an analysis of 2.3 million participants in the Pooling Project of Prospective Studies of Die… Co-author DOI 10.1007/s10654-026-01418-x↗
  3. Long-term exposure to outdoor air pollutants and risk of pancreatic cancer in a large prospective U.S.-based cohort. Co-author DOI 10.1038/s41370-026-00929-9↗
  4. Metabolomic profiling of genotype-derived ABO blood group, secretor status, and Lewis antigens and association with pancreatic ductal adenocarcinoma risk. Last author DOI 10.1093/aje/kwag055↗
  5. Lipid biomarkers of habitual alcohol intake and associations with pancreatic cancer risk. Co-author DOI 10.1093/jnci/djaf288↗
  6. Different diabetes types and pancreatic ductal adenocarcinoma: a Mendelian randomization and pathway/gene-set analysis. Last author DOI 10.1093/jnci/djaf308↗
  7. Prediagnosis diabetes, life-course body mass index and physical activity, and pancreatic cancer survival in older adults. Last author DOI 10.1093/jncics/pkaf110↗
  8. Is Heavy Alcohol Use Associated With Young-Onset Pancreatic Cancer? Co-author DOI 10.1200/jco-25-03092↗
  9. Novel Genetic Risk Loci for Pancreatic Ductal Adenocarcinoma Identified in a Genome-wide Study of African Ancestry Individuals Co-author DOI 10.64898/2026.04.21.26351329↗
  10. Association between prediagnostic serum metabolites and pancreatic ductal adenocarcinoma risk in two prospective cohorts. Last author DOI 10.1002/ijc.35479↗
  11. Allelic effects on KLHL17 expression underlie a pancreatic cancer genome-wide association signal at chr1p36.33. Co-author DOI 10.1038/s41467-025-59109-2↗
  12. Prediagnostic whole-blood cadmium and molybdenum associated with pancreatic cancer in an American cohort. Co-author DOI 10.1093/aje/kwae165↗
  13. Alcohol intake and pancreatic cancer risk: An analysis from 30 prospective studies across Asia, Australia, Europe, and North America. Co-author DOI 10.1371/journal.pmed.1004590↗
  14. Circulating microRNAs in association with pancreatic cancer risk within 5 years. Co-author DOI 10.1002/ijc.34956↗
  15. Sleep and Risk of Pancreatic Cancer in the UK Biobank. Last author DOI 10.1158/1055-9965.epi-23-0983↗
  16. Genome-Wide Analysis to Assess if Heavy Alcohol Consumption Modifies the Association between SNPs and Pancreatic Cancer Risk. Co-author DOI 10.1158/1055-9965.epi-24-0096↗
  17. Autoimmune conditions and pancreatic cancer risk in older American adults. Last author DOI 10.1002/ijc.34235↗
  18. Lipidomics and pancreatic cancer risk in two prospective studies. Last author DOI 10.1007/s10654-023-01014-3↗
  19. Pancreatic cancer: Are all plant-based diets the same? Co-author DOI 10.1016/j.ajcnut.2022.12.009↗
  20. Genetic Susceptibility to Nonalcoholic Fatty Liver Disease and Risk for Pancreatic Cancer: Mendelian Randomization. Co-author DOI 10.1158/1055-9965.epi-23-0453↗
  21. Nested Case-Control Studies Investigating Serum Perfluorooctanoate and Perfluorooctane Sulfonate Levels and Pancreatic Ductal Adenocarcinoma in Two Cohorts. Last author DOI 10.1289/ehp13208↗
  22. The age-dependent association of risk factors with pancreatic cancer. Co-author DOI 10.1016/j.annonc.2022.03.276↗
  23. Adherence to 5 Diet Quality Indices and Pancreatic Cancer Risk in a Large US Prospective Cohort. Last author DOI 10.1093/aje/kwac082↗
  24. Body Mass Index Trajectories Across the Adult Life Course and Pancreatic Cancer Risk. Last author DOI 10.1093/jncics/pkac066↗
  25. A 584 bp deletion in CTRB2 inhibits chymotrypsin B2 activity and secretion and confers risk of pancreatic cancer. Co-author DOI 10.1016/j.ajhg.2021.09.002↗
  26. Hepcidin-regulating iron metabolism genes and pancreatic ductal adenocarcinoma: a pathway analysis of genome-wide association studies. Last author DOI 10.1093/ajcn/nqab217↗
  27. Are Prediagnostic Biomarkers of Inflammation and an Empirically Based Proinflammatory Dietary Pattern Associated With Poorer Pancreatic Cancer Survival? Co-author DOI 10.1093/jnci/djab043↗
  28. Light at Night and Risk of Pancreatic Cancer in the NIH-AARP Diet and Health Study. Last author DOI 10.1158/0008-5472.can-20-2256↗
  29. Smoking Modifies Pancreatic Cancer Risk Loci on 2q21.3. Last author DOI 10.1158/0008-5472.can-20-3267↗
  30. Hemochromatosis, Iron Overload-Related Diseases, and Pancreatic Cancer Risk in the Surveillance, Epidemiology, and End Results (SEER)-Medicare. Last author DOI 10.1158/1055-9965.epi-21-0476↗
  31. A multilayered post-GWAS assessment on genetic susceptibility to pancreatic cancer. Co-author DOI 10.1186/s13073-020-00816-4↗
  32. A Transcriptome-Wide Association Study Identifies Novel Candidate Susceptibility Genes for Pancreatic Cancer. Co-author DOI 10.1093/jnci/djz246↗
  33. Associations between metabolites and pancreatic cancer risk in a large prospective epidemiological study. Co-author DOI 10.1136/gutjnl-2019-319811↗
  34. Genome-Wide Association Study Data Reveal Genetic Susceptibility to Chronic Inflammatory Intestinal Diseases and Pancreatic Ductal Adenocarcinoma Risk. Last author DOI 10.1158/0008-5472.can-20-0447↗
  35. Genetic and Circulating Biomarker Data Improve Risk Prediction for Pancreatic Cancer in the General Population. Co-author DOI 10.1158/1055-9965.epi-19-1389↗
  36. Associations between Genetically Predicted Blood Protein Biomarkers and Pancreatic Cancer Risk. Co-author DOI 10.1158/1055-9965.epi-20-0091↗
  37. Genome-Wide Gene-Diabetes and Gene-Obesity Interaction Scan in 8,255 Cases and 11,900 Controls from PanScan and PanC4 Consortia. Co-author DOI 10.1158/1055-9965.epi-20-0275↗
  38. Serum selenium and pancreatic cancer: a prospective study in the Prostate, Lung, Colorectal and Ovarian Cancer Trial cohort. Last author DOI 10.1007/s10552-019-01147-5↗
  39. Inflammatory Potential of Diet, Inflammation-Related Lifestyle Factors, and Risk of Pancreatic Cancer: Results from the NIH-AARP Diet and Health Study. Co-author DOI 10.1158/1055-9965.epi-19-0250↗
  40. Inflammatory potential of diet and risk of pancreatic cancer in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial. Co-author DOI 10.1002/ijc.31271↗
  41. Genome-wide meta-analysis identifies five new susceptibility loci for pancreatic cancer. Co-author DOI 10.1038/s41467-018-02942-5↗
  42. Pancreatic cancer risk is modulated by inflammatory potential of diet and ABO genotype: a consortia-based evaluation and replication study. Co-author DOI 10.1093/carcin/bgy072↗
  43. Pancreatic cancer incidence trends: evidence from the Surveillance, Epidemiology and End Results (SEER) population-based data. Last author DOI 10.1093/ije/dyx232↗
  44. Is the Women's Health Initiative (WHI) Dietary Modification Associated With a Reduced Risk of Pancreatic Cancer? Co-author DOI 10.1093/jnci/djx139↗
  45. The Association of Recently Diagnosed Diabetes and Long-term Diabetes With Survival in Pancreatic Cancer Patients: A Pooled Analysis. Co-author DOI 10.1097/mpa.0000000000000989↗
  46. Human oral microbiome and prospective risk for pancreatic cancer: a population-based nested case-control study. Co-author DOI 10.1136/gutjnl-2016-312580↗
  47. Helicobacter pylori infection, chronic corpus atrophic gastritis and pancreatic cancer risk in the European Prospective Investigation into Cancer and Nutrition… Co-author DOI 10.1002/ijc.30590↗
  48. A Cohort Study of Adolescent and Midlife Diet and Pancreatic Cancer Risk in the NIH-AARP Diet and Health Study. Last author DOI 10.1093/aje/kwx036↗
  49. Dietary patterns and risk of pancreatic cancer: a systematic review. Co-author DOI 10.1093/nutrit/nux038↗
  50. No Association Between Nonsteroidal Anti-inflammatory Drug Use and Pancreatic Cancer Incidence and Survival. Co-author DOI 10.1097/mpa.0000000000000809↗

Grants 3

  1. Whole Genome Scan in the Pancreatic Cancer Cohort Consortium (PanScan) ZIACP010193↗
  2. Physical Activity, Energy Balance, and Cancer ZIACP010197↗
  3. Biochemical, molecular, and dietary studies for pancreatic cancer within PLCO ZIACP010202↗

Closest collaborators

The 25 strongest of 179 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Demetrius Albanes · 22 shared papers, 1 shared grant, 2011–2026 · strength 3.05
  2. Rachael Solomon · 2 shared grants, 2025 · strength 2.15
  3. Stephanie J. Weinstein · 15 shared papers, 2011–2026 · strength 1.62
  4. Ting Zhang · 5 shared papers, 2023–2026 · strength 1.36
  5. Sachelly Julián‐Serrano · 4 shared papers, 2021–2023 · strength 0.80
  6. Xiao‐Ou Shu · 6 shared papers, 2013–2026 · strength 0.71
  7. Debra T. Silverman · 8 shared papers, 2011–2026 · strength 0.64
  8. Gloria M. Petersen · 14 shared papers, 2011–2022 · strength 0.63
  9. Herbert Yu · 5 shared papers, 2013–2025 · strength 0.61
  10. Laufey Thora Amundadottir · 10 shared papers, 2013–2022 · strength 0.56
  11. Qiuyin Cai · 3 shared papers, 2020–2026 · strength 0.54
  12. Rena R. Jones · 2 shared papers, 2021–2026 · strength 0.52
  13. Sabine Naudin · 2 shared papers, 2023–2026 · strength 0.52
  14. Veronica Wendy Setiawan · 2 shared papers, 2024–2026 · strength 0.47
  15. Fei Ye · 2 shared papers, 2024–2026 · strength 0.47
  16. Hui Cai · 2 shared papers, 2024–2026 · strength 0.47
  17. Jordan D. Berlin · 2 shared papers, 2024–2026 · strength 0.47
  18. Brian Matthew Wolpin · 9 shared papers, 2013–2022 · strength 0.43
  19. Wei Zheng · 5 shared papers, 2013–2024 · strength 0.43
  20. Joshua Neil Sampson · 4 shared papers, 2013–2023 · strength 0.42
  21. Michaël Pollak · 7 shared papers, 2011–2020 · strength 0.41
  22. Simran Arjani · 2 shared papers, 2022–2023 · strength 0.41
  23. Kristin E. Anderson · 12 shared papers, 2011–2018 · strength 0.39
  24. Noah Charles Peeri · 1 shared paper, 2026 · strength 0.39
  25. Harvey A. Risch · 7 shared papers, 2013–2022 · strength 0.38

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.